Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.22.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Revenue        
Revenue
Other revenue 45 266 985 888
Total revenue 45 266 985 888
Operating expenses:        
Research and development, net of reimbursements 4,662 3,631 9,031 7,907
General and administrative 3,233 1,710 4,968 3,428
Total operating expenses 7,895 5,341 13,999 11,335
Loss from operations (7,850) (5,075) (13,014) (10,447)
Other income:        
Interest income - net 83 54 118 106
Total other income 83 54 118 106
Net loss $ (7,767) $ (5,021) $ (12,896) $ (10,341)
Net loss per common share – basic and diluted (in Dollars per share) $ (0.33) $ (0.25) $ (0.56) $ (0.54)
Weighted average common shares outstanding – basic and diluted (in Shares) 23,731,886 20,231,278 22,942,317 19,308,487